Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Equity Income: 2020-2021

Historic Equity Income for Insight Molecular Diagnostics (IMDX) over the last 1 years, with Mar 2021 value amounting to -$270,000.

  • Insight Molecular Diagnostics' Equity Income rose 17.93% to -$270,000 in Q1 2021 from the same period last year, while for Mar 2021 it was -$1.5 million, marking a year-over-year change of. This contributed to the annual value of -$270,000 for FY2021, which is 82.55% up from last year.
  • As of Q1 2021, Insight Molecular Diagnostics' Equity Income stood at -$270,000, which was up 37.93% from -$435,000 recorded in Q4 2020.
  • In the past 5 years, Insight Molecular Diagnostics' Equity Income ranged from a high of -$270,000 in Q1 2021 and a low of -$482,000 during Q3 2020.
  • Its 2-year average for Equity Income is -$363,400, with a median of -$329,000 in 2020.
  • Data for Insight Molecular Diagnostics' Equity Income shows a peak YoY rose of 17.93% (in 2021) over the last 5 years.
  • Insight Molecular Diagnostics' Equity Income (Quarterly) stood at -$435,000 in 2020, then increased by 17.93% to -$270,000 in 2021.
  • Its last three reported values are -$270,000 in Q1 2021, -$435,000 for Q4 2020, and -$482,000 during Q3 2020.